It looks like a huge short squeeze is being set up.
1. Switch the "Short Interest History (%)" to "YTD" 2. Notice that as of May 15, the share price was at $4.86 and the short interest was 16.83%. 3. Notice as short interest started increasing (16.83% to 20%) until around June 16th, the share price was $4.58. Shorts managed to push the stock slightly lower. 4. The next 3 weeks, we saw the share price jump to $8.04 (52-week high), all while short interest continued to climb to about 22.5% (midway between 20% and 25%) up to the $8 peak. In fact, short interest continued to climb to 24.6% even as the share price continued to drop to a low of $5.66. 5. This means any shorts shorting and holding from the past 3 months would be averaged in at around $6 whereas recent shorts would be only positioned in slightly higher.
What does this mean??? Shorts have been averaging up at first (a good thing for shorts), and then averaging down since July 7 ( a bad thing) for their short positions. This translates to huge pain in the works for shorts as the share price continues to climb and approach $7. Most shorts are underwater with only a few above water. I suspect we'll see something very interesting play out soon.
Additionally, institutions have been buying up the past 2 weeks.
1. Go to Nasdaq's website and search for institutional holdings for IMGN. It's at 86.34%
2. If you copy this URL and go to archive (dot) is and paste this into that site, it'll give you the results from 2 weeks ago when I took a snapshot of IMGN institutional holding on August 4. Institutions held 76.35% at that time.
Go to gurufocus (dot) com/ownership/IMGN <-- This shows the short interest graph.
Riding this to 9 lol
Hmmm not sure what to say about this stock right now. The 1 month chart shows lower lows, lower highs. That's usually a bearish move.
Why is it that most reports about this company are slanted to the negative? Why don't they tout the 6 company owned products and the 16 partnerships? One article stated that they had missed their projections three quarters in a row-fakenews?????
Uptrend appears unbroken. Stock didn't want to stay down yesterday.
MicroCap News Alert: - Startup - Clean Energy Technologies (CETY) buys General Electric “Heat Recovery Systems Division” and within 2 years achieves break-even with sales now set to soar and to be profitable.
CETY announced today the launch of Pacific Rim Initiative with over 20 locations already identified by CETY and PPA power company authorities.
Early orders likely to exceed $25 million in annuitized sales. 12 month target price $.25
CETY/GE proprietary oil-free magnetic levitation turbine technology shatters the competition’s old oil-lubricated screw expander technologies.
Company expects to up list to NASDAQ.
CETY's implementation includes creative lease financing structure, that facilitates rapid adoption and ease of entry with long-term payment structure that allows the utility user to align its investment with actual energy and cost savings realized through use of Clean Cycle™ units," said Kam Mahdi, CEO of CETY.
CETY being welcomed with red carpet to largest markets in the world in need of clean energy.
Clean Energy Technologies (CETY) Launches Pacific Rim Initiative
COSTA MESA, Calif. , Aug. 15, 2017 Clean Energy Technologies, Inc. (OTC: CETY) announced that CETY officially launched its new campaign to deliver its energy solutions to Island Nations utilities at the ...
Any scientists here? Anyone agrees with their notion that CD33 is not the reason for SGEN's failure?
Time to sell above 6! This stock is likely to end up flat again today, unable to hold any gains.
Sold at 6.11, rebought at 5.82. WEEE!!!!!!
I think we'll see $6+ today. 5% increase gets us to $6.11. I think we might settle around $6.05 today (slightly under 4%)
If we are to go off the RSI then you could argue that a pull back next day or so could occur on IMGN before rallying up. the other week awe*some*sto-cks alerted this company i think. google them .
Jefferies Reaffirms Their Buy Rating on ImmunoGen - Analyst Ratings
August 7, 2017 Jefferies analyst Michael Yee reiterated a Buy rating on ImmunoGen (NASDAQ: IMGN) yesterday and set a price target of $9. The company's shares closed on Fr
I am betting this stock won't make it to years end without being bought out. This company has many drugs in various places in the pipeline, it is absolutely a buyout target, and buying with these short attacks is almost too easy, your about to watch this run in my opinion, either way short or long GLTA
United Therapeutics Corp. stock surges 9% on report of possible bids for company
If we are to go off the RSI then you could argue that a pull back next day or so could occur on IMGN before rallying up. Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from Awe.Some.Sto-ck.s.